TORNTPHARM · Health Care · 2026-08-21

Torrent Pharmaceuticals Ltd

5.3★ FairSolid +5.8Stage 2 · wk 39In scan: Breakout WatchMARKET: BULL RISING · 2026-08-21
₹4,896.5
-2.17% today
₹1,86,247 Cr · Large cap
About this companyHealth Care· Pharmaceuticals
Expand ▾

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Visit company website →
P/E (TTM)
70.8
Forward 48.2
Earnings Growth (YoY)
-21.8%
Revenue +41.8%
ROE
+17.0%
Profit margin +15.5%
Dividend Yield
0.85%
P/B 18.2
vs 52W High
-4.4%
₹3,490.8 lo₹5,122.8 hi
4.4% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 39
1w13w26w
Week 39 — mature, watch for distribution
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
14.9%
200 DMA: ₹4,260.1 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.34x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -0.6% vs MA50 +4.4%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↑ Building
Stage 2%
55.5%
20d Δ
+3.9pp
1M return
+2.7%
3M return
+9.6%
Sector Stage-2 % · last 20 days
This stock ranks #26 of 84 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
56.1%
20d Δ
+5.6pp
1M return
+2.7%
3M return
+10.4%
Industry Stage-2 % · last 20 days
Ranks #21 of 58 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-05-29 → 2026-08-21
S2 17w
S2 51w
S2 16w
S2 40w
2023-05-292026-08-21
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 17w → S3 8w → S2 51w → S3 11w → S2 3w → S3 2w → S4 7w → S1 10w → S2 16w → S3 2w → S2 40w current
Total tracked: 168 weeks across 11 stage runs.
1M
-3.3%
3M
+9.1%
6M
+15.7%
YTD
+30.0%
1Y
+36.3%
Scan Membership
Breakout Watch
Latest: 2025-11-17
3 appearances in last 60 days. First seen: 2025-01-28.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-21S2
Wk 39 · Vol —x
2026-08-20S2
Wk 39 · Vol —x
2026-08-19S2
Wk 39 · Vol —x
2026-08-18S2
Wk 38 · Vol —x
2026-08-17S2
Wk 38 · Vol —x
2026-08-14S2
Wk 38 · Vol —x
2026-08-13S2
Wk 38 · Vol —x
2026-08-12S2
Wk 38 · Vol —x
2026-08-11S2
Wk 37 · Vol —x
2026-08-10S2
Wk 37 · Vol —x
2026-08-07S2
Wk 37 · Vol —x
2026-08-06S2
Wk 37 · Vol —x
Sector Peers — Stage 2All →
NEULANDLAB
wk 12 · -1.5% from hi
9.0
ALIVUS
wk 19 · -3.4% from hi
9.0
DIVISLAB
wk 14 · -0.0% from hi
8.8
SAILIFE
wk 25 · -1.0% from hi
8.8
SHILPAMED
wk 15 · -0.9% from hi
8.6
Moving averages & range
50 DMA
₹4,826.6
200 DMA
₹4,260.1
52W High
₹5,122.8
52W Low
₹3,490.8
5D Low
₹4,896.5
Resistance levels (recent highs)
20d High
₹5,122.8
60d High
₹5,122.8
120d High
₹5,122.8
250d High
₹5,122.8
Next resistance
+4.6%
to 20d High

All analytics based on EOD data. Data as of 2026-08-21. Past data patterns are not indicative of future results. This page is a data analytics tool only.